Skip to main content
SpringerLink
Log in

Intravenous Cyclosporine for the Treatment of Severe Steroid Refractory Ulcerative Colitis: What is the Cost?

  • Original Contribution
  • Published:
Diseases of the Colon & Rectum

PURPOSE

Intravenous cyclosporine often is used to treat patients with severe steroid refractory colitis secondary to ulcerative colitis in an attempt to avoid urgent total abdominal colectomy. The purpose of this study was to evaluate the success and cost of cyclosporine.

METHODS

A retrospective, chart review of all patients from 1996 to 2002 who were treated with cyclosporine and/or had a three-stage ileal pouch-anal anastomosis for severe steroid refractory colitis at our institution was performed. Patients were divided into three groups: TAC and CyA: patients who failed cyclosporine and had urgent total abdominal colectomy on the same admission; TAC no CyA: patients who had an urgent total abdominal colectomy without cyclosporine; and CyA only: patients treated successfully with cyclosporine and discharged without surgery. A subgroup of patients who had an ileal pouch-anal anastomosis was identified from each group. Cost data were obtained from the hospital’s financial records.

RESULTS

Forty-one patients (25 males) were identified. Twenty-nine patients received cyclosporine for severe steroid refractory colitis. Of these, 18 (62 percent) failed and underwent total abdominal colectomy on the same admission. Eleven (38 percent) responded to the cyclosporine and were discharged. Of the 11, 4 never had surgery, 1 had a three-stage ileal pouch-anal anastomosis, 5 had a two-stage ileal pouch-anal anastomosis, and 1 had a total abdominal colectomy only. Only 14 percent of patients avoided colectomy in the long-term. Complications of cyclosporine occurred in 8 patients (28 percent), and surgical complications occurred in 12 patients.

CONCLUSIONS

The highest costs, highest length of stay, and highest number of overall complications were found in the group of patients who failed intravenous cyclosporine and required colectomy during the same hospitalization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. FC Edwards SC Truelove (1963) ArticleTitleThe course and prognosis of ulcerative colitis: part 1: short-term prognosis Gut 41 300–8

    Google Scholar 

  2. JC Goligher DC Hoffman FT Dombal ParticleDe (1970) ArticleTitleSurgical treatment of severe attacks of ulcerative colitis with special reference to the advantage of early operation BMJ 9 389–407

    Google Scholar 

  3. G McCormack PA McCormick JM Hyland DP O’Donoghue (2002) ArticleTitleCyclosporin therapy in severe ulcerative colitis. Is it worth the effort? Dis Colon Rectum 45 1200–5 Occurrence Handle10.1007/s10350-004-6393-8 Occurrence Handle12352237

    Article  PubMed  Google Scholar 

  4. FA Rowe JH Walker LC Karp EA Vasiliauskas SE Plevy SR Targan (2000) ArticleTitleFactors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis Am J Gastroenterol 95 2000–8 Occurrence Handle10.1111/j.1572-0241.2000.02186.x Occurrence Handle10950049

    Article  PubMed  Google Scholar 

  5. A Kornbluth S Lichtiger D Present S Hanauer (1994) ArticleTitleLong-term results of oral cyclosporin in patients with severe ulcerative colitis: a double-blind, randomized, multi-center trial [meeting abstract] Gastroenterology 106 A714

    Google Scholar 

  6. S Lichtiger DH Present A Kornbluth et al. (1994) ArticleTitleCyclosporine in severe ulcerative colitis refractory to steroid therapy N Engl J Med 330 1841–5 Occurrence Handle10.1056/NEJM199406303302601 Occurrence Handle8196726

    Article  PubMed  Google Scholar 

  7. R Carbonnel A Boruchowicz B Duclos et al. (1996) ArticleTitleIntravenous cyclosporine in attacks of ulcerative colitis short-term and long-term responses Dig Dis Sci 41 2471–6 Occurrence Handle9011460

    PubMed  Google Scholar 

  8. Cleverly W. Essentials of healthcare finance. Gaithersburg: Aspen Publishers, 1992

  9. RD Cohen R Stein SB Hanauer (1999) ArticleTitleIntravenous cyclosporine in ulcerative colitis: a five-year experience Am J Gastroenterol 94 1587–92 Occurrence Handle10.1111/j.1572-0241.1999.01149.x Occurrence Handle10364029

    Article  PubMed  Google Scholar 

  10. J Santos S Baudet F Casellas L Guarner J Vilaseca JR Malagelada (1995) ArticleTitleEfficacy of intravenous cyclosporine for steroid refractory attacks of ulcerative colitis J Clin Gastroenterol 20 285–9 Occurrence Handle7665815

    PubMed  Google Scholar 

  11. M Sternthal J George AA Kornblut et al. (1996) ArticleTitleToxicity associated with the use of cyclosporin in patients with inflammatory bowel disease [meeting abstract] Gastroenterology 110 A1019

    Google Scholar 

  12. R Kozarek C Bedard D Patterson et al. (1995) ArticleTitleCyclosporin use in the precolectomy chronic ulcerative colitis patient: a community experience and its relationship to prospective and controlled clinical trials Am J Surg 90 2093–6

    Google Scholar 

  13. SR Gurudu LH Griffel RJ Gialanella KM Das (1999) ArticleTitleCyclosporine therapy in inflammatory bowel disease short-term and long-term results J Clin Gastroenterol 29 151–4 Occurrence Handle10.1097/00004836-199909000-00009 Occurrence Handle10478875

    Article  PubMed  Google Scholar 

  14. PR Fleshner R Michelassi M Rubin SB Hanauer SE Plevy SR Targan (1995) ArticleTitleMorbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin Dis Colon Rectum 38 1241–5 Occurrence Handle10.1007/BF02049146 Occurrence Handle7497833

    Article  PubMed  Google Scholar 

  15. G Jarnerot P Rolny H Sandberg-Gertzen (1985) ArticleTitleIntensive intravenous treatment of ulcerative colitis Gastroenterology 89 1005–13 Occurrence Handle3930339

    PubMed  Google Scholar 

  16. CG Loftus EV Loftus WJ Sandborn (2003) ArticleTitleCyclosporin for refractory ulcerative colitis Gut 52 172–3 Occurrence Handle10.1136/gut.52.2.172 Occurrence Handle12524395

    Article  PubMed  Google Scholar 

  17. J Arts M Zeegers G D’Haens et al. (2001) ArticleTitleLong-term outcome of treatment with cyclosporine IV for patients with intractable ulcerative colitis [meeting abstract] Gastroenterology 120 A3169

    Google Scholar 

  18. M Pinna-Pintor P Arese R Bona et al. (2000) ArticleTitleSevere steroid-unresponsive ulcerative colitis outcomes of restorative proctocolectomy in patients undergoing cyclosporine treatment Dis Colon Rectum 43 609–14 Occurrence Handle10826419

    PubMed  Google Scholar 

  19. AM Scott GA Myers BA Harms (1997) ArticleTitlePneumocystis carinii pneumonia postrestorative proctocolectomy for ulcerative colitis: a role for perioperative prophylaxis in the cyclosporine era? Report of a case and review of the literature Dis Colon Rectum 40 973–6 Occurrence Handle10.1007/BF02051208 Occurrence Handle9269817

    Article  PubMed  Google Scholar 

  20. VA Quan BP Saunders BH Hicks GA Sladen (1997) ArticleTitleLesson of the week: cyclosporine treatment for ulcerative colitis complicated by fatal Pneumocystis carinii pneumonia BMJ 314 363–6 Occurrence Handle9040337

    PubMed  Google Scholar 

  21. MB Smith SB Hanauer (1992) ArticleTitlePneumocystis carinii pneumonia during cyclosporine therapy for ulcerative colitis N Engl J Med 327 497–8

    Google Scholar 

  22. G D’Haens L Lemmens K Geboes et al. (2001) ArticleTitleIntravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis Gastroenterology 120 1323–9 Occurrence Handle10.1053/gast.2001.23983 Occurrence Handle11313301

    Article  PubMed  Google Scholar 

  23. WJ Sandborn WJ Tremaine (1992) ArticleTitleCyclosporine treatment of inflammatory bowel disease Mayo Clin Proc 67 981–90 Occurrence Handle1434859

    PubMed  Google Scholar 

  24. GM Hyde DP Jewell MG Kettlewell NJ Mortensen (2001) ArticleTitleCyclosporine for severe ulcerative colitis does not increase the rate of perioperative complications Dis Colon Rectum 44 1436–40 Occurrence Handle11598471

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Surgery, Medicine, and Health Evaluation Sciences, The Milton S. Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania

    Lisa S. Poritz M.D., William A. Rowe M.D., Brian R. Swenson M.D., Christopher S. Hollenbeak Ph.D. & Walter A. Koltun M.D.

Authors
  1. Lisa S. Poritz M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William A. Rowe M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian R. Swenson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christopher S. Hollenbeak Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Walter A. Koltun M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa S. Poritz M.D..

About this article

Cite this article

Poritz, L., Rowe, W., Swenson, B. et al. Intravenous Cyclosporine for the Treatment of Severe Steroid Refractory Ulcerative Colitis: What is the Cost?. Dis Colon Rectum 48, 1685–1690 (2005). https://doi.org/10.1007/s10350-005-0128-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-005-0128-3

Key words

Search

Navigation